August 2012 FDA Recall Hydromorphone Hydrochloride by Hospira Inc. (D-020-2013 - Superpotent (Single Ingredient) Drug)

This Class I drug recall was voluntarily initiated by Hospira Inc. on August 15, 2012 for the product Hydromorphone Hydrochloride. The FDA reported the reason for recall as superpotent (single ingredient) drug. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-020-2013

Reason for Recall
Superpotent (Single Ingredient) Drug: The prefilled cartridge unit has been found to be overfilled and contain more than the 1 mL labeled fill volume.
Initiated
08-15-2012
Reported
10-31-2012
Quantity
216,880 cartridge units

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
HYDROmorphone HCl Injection, USP, 2 mg/mL, 1 mL fill in a 2.5 mL Carpuject prefilled cartridge unit, packaged in 10-count Carpujects per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1312-30, Barcode (01) 1 030409 131230 9 (carton), (01) 0 030409 131230 2 (cartridge unit).

Batch or Lot Expiration Information

Lot# Lot 12720LL, Exp 12/01/13